MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2025 International Congress

    Detection and classification of Parkinson’s disease from neuroimaging modalities using machine learning and artificial intelligence: a systematic review

    F. Ebrahimian Sadabad, P. Honhar, S. Houshi, F. Nejati, S. Bagherieh, A. Brackett, F. Yazdanpanah, S. Cayir, M. Hosseini, H. Tagare, D. Matuskey (New Haven, USA)

    Objective: This systematic review evaluates performance of machine learning (ML) and artificial intelligence (AI) techniques applied to neuroimaging modalities in differentiating Parkinson’s disease (PD) patients…
  • 2025 International Congress

    Striatal dopamine- and basal forebrain cholinergic-dependent brain metabolism and cognition in Parkinson’s disease

    HS. Yoo, JH. Lee, M. Park, SJ. Ahn, JH. Lee, YH. Ryu, CH. Lyoo (Seoul, Republic of Korea)

    Objective: To explore the interrelation of striatal dopamine, cholinergic basal forebrain volume, brain metabolism, and cognition in PD. Background: Parkinson’s disease (PD) involves multiple neurotransmitter…
  • 2025 International Congress

    Cerebral Glucose Metabolic Features of GBA-Parkinson’s Disease as a window into cognitive impairment

    P. Mitrotti, R. Calabrese, M. Picascia, L. Gallo, R. Malito, A. Panzacchi, C. Galandra, M. Todisco, R. Zangaglia, D. Perani, A. Chiti, EM. Valente, C. Tassorelli, S. Camminiti, M. Avenali (Pavia, Italy)

    Objective: to investigate cerebral glucose metabolism via fluorodeoxyglucose positron emission tomography (FDG-PET) and its correlation to clinical features in Parkinson’s disease (PD) patients with GBA1…
  • 2025 International Congress

    A Multi-Transcriptional Risk Score Approach to Parkinson’s Disease Prediction

    L. Gilchrist, O. Pain, A. Noyce, K. Brolin, M. Periñán, P. Proitsi (London, United Kingdom)

    Objective: To improve the prediction of Parkinson’s disease (PD) by examining aggregate profiles of gene expression in the form of transcriptional risk scores (TRS). Background:…
  • 2025 International Congress

    Investigating the Global Genetic Spectrum of Monogenic Parkinson’s Disease and Parkinsonism

    L. Lange, M. Makarious, M. Avenali, S. Bardien, M. Doquenia, C. Galandra, P. Heutink, J. Junker, Y. Kanana, I. Keller Sarmiento, K. Kumar, H. Leonard, K. Levine, SY. Lim, K. Lohmann, N. Mencacci, M. Nalls, AH. Tan, J. Trinh, EM. Valente, C. Blauwendraat, S. Bandres-Ciga, A. Singleton, ZH. Fang, C. Klein (Bethesda, USA)

    Objective: To investigate known pathogenic and risk variants linked to Parkinson’s disease (PD) at a global, multi-ancestry scale. Background: Genetic forms of PD have been…
  • 2025 International Congress

    Mutations of the VPS13A gene in a patient with Early-Onset Parkinson’s Disease: A case report.

    H. Pacheco, V. Gómez, C. Sánchez, L. Núñez (Mexico, Mexico)

    Objective: To describe the case of a patient with early-onset Parkinson's Disease (PD) with variants of the VPS13A gene. Background: The vacuolar protein sorting 13A…
  • 2025 International Congress

    Examining the Gut Microbiome in Parkinson Patients with GBA Mutations

    H. Dainton-Howard, A. Keshavarzian, A. Kirby, C. Goetz (Chicago, USA)

    Objective: Gut dysbiosis is implicated in Parkinson disease (PD) pathogenesis, but less is known about the interaction of PD associated gene variants and gut microbiota.…
  • 2025 International Congress

    Advancing Global Training and Capacity Building in Parkinson’s Genetics through GP2

    MT. Periñan, S. Dey, S. Finch, H. Leonard, M. Makarious, K. Atterling Brolin, A. Zirra, K. Step, V. van Midden, YW. Tay, Y. Mecheri, L. Faria-Costa, E. Fernandez-Toledo, V. Flores-Ocampo, C. Shambetova, A. Noyce, S. Bandres-Ciga, GP2. Genetics Program (Sevilla, Spain)

    Objective: To promote and facilitate learning by providing resources and expertise to address the training needs of the Global Parkinson’s Genetics Program (GP2; www.gp2.org) and…
  • 2025 International Congress

    Rare Variants, Copy Number Variations, and Heritability Estimates in a Pilot Cohort of Egyptians with Parkinson’s Disease

    M. Yousef, A. El-Hosseiny, A. Nagano, A. Atputhavadivel, E. Khedr, M. William, A. Shalash, G. Fawy, S. El-Shafie, S. El-Jaafary, M. Koraym, Y. Salah, S. Elfarrash, Y. Elsaid, A. Gabr, N. Shebl, L. Aly, N. Abdelwahhab, T. Belal, N. Elsayed, M. El-Gamal, S. Elgamal, S. Ragab, J. Mekky, M. Salama, M. Rizig (Cairo, Egypt)

    Objective: To explore the genetic architecture of Parkinson's disease (PD) in Egypt, addressing the underrepresentation of this population in PD genetics research. Background: Genetic studies…
  • 2025 International Congress

    Predictors of Cognitive Impairments and Mood Disorders after Subthalamic Deep Brain Stimulation in Patients with Parkinson’s Disease

    O. Alenikova, M. Dymkovskaya, A. Bunyak, E. Mykitchuk, S. Kantsevich (Minsk, Belarus)

    Objective: We aimed to determine the predictors of cognitive decline and mood disorders after STN-DBS in PD. Background: Cognitive impairment and mood disorders are the…
  • « Previous Page
  • 1
  • …
  • 47
  • 48
  • 49
  • 50
  • 51
  • …
  • 181
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • #25179 (not found)
  • Effect of marijuana on Essential Tremor: A case report
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley